Best supportive care of the patient with oesophageal cancer

RC Pichel, A Araújo, VDS Domingues, JN Santos… - Cancers, 2022 - mdpi.com
Simple Summary Oesophageal cancer is the sixth leading culprit of cancer-related mortality,
and the majority of the patients with advanced disease are treated with best supportive care …

[PDF][PDF] Optimal management of dysphagia in patients with inoperable esophageal cancer: current perspectives

S Mohapatra, A Santharaman, K Gomez… - Cancer Management …, 2022 - Taylor & Francis
The majority of patients with esophageal cancer are diagnosed at an advanced, incurable
stage. Palliation of symptoms, specifically dysphagia, is a crucial component to improve …

New trends in esophageal cancer management

C Gronnier, D Collet - Cancers, 2021 - mdpi.com
Esophageal cancer (EC) is a condition with a five-year survival rate of around 15% for all
stages considered. It is the eighth most common cancer and the sixth worst prognosis …

[PDF][PDF] Local ablative treatment improves survival in ESCC patients with specific metastases, 2010–2016: A population-based SEER analysis

H Yang, K Wang, Y Li, S Li, L Yuan, H Ge - Frontiers in Oncology, 2022 - frontiersin.org
Background We aimed to explore the role of local ablative treatment (LAT) in metastatic
esophageal squamous cell cancer (ESCC) patients who received chemotherapy and …

Palliation of dysphagia in patients with non-curable esophageal cancer–a retrospective Danish study from a highly specialized center

C Egeland, LA Bazancir, NH Bui, L Baeksgaard… - Supportive Care in …, 2022 - Springer
Purpose A majority of the patients with esophageal cancer (EC) suffer from dysphagia.
Several endoscopic treatment options are available such as stent placement, argon plasma …

Phase I trial of hypofractionated chemoradiotherapy in the palliative management of esophageal and gastro-esophageal cancer

S Sridharan, F Day, J Loh, J Lynam, J Smart, B Holt… - Radiation …, 2022 - Springer
Background Many patients with incurable esophageal cancer (ECa) present with dysphagia
as their predominant symptom. Currently there is no consensus on how best to initially …

Chemoimmunotherapy for esophageal squamous cell carcinoma—Summary and discussion of recent clinical trials

Z Zhang, J Huang, Y Xu, H Luo - MedComm–Future Medicine, 2023 - Wiley Online Library
As a kind of carcinoma with increasing morbidity, poor prognosis, and high mortality,
esophageal squamous cell carcinoma (ESCC) is challenging for clinical management …

[PDF][PDF] Palliative care for patients with gastroesophageal cancer at all stages: a narrative review

K DeCarli, D Guyer, K Almhanna - Annals of Palliative Medicine, 2024 - cdn.amegroups.cn
Key Content and Findings: A total of 119 articles were identified and screened in our
database search. Of these, 22 full text articles met inclusion criteria and were reviewed …

[HTML][HTML] 早期食管病变内镜黏膜下剥离术后辅助治疗人群的预测模型

宋文轩, 刘航, 任祥凤, 陈鑫 - 世界华人消化杂志, 2022 - wjgnet.com
早期食管病变内镜黏膜下剥离术后辅助治疗人群的预测模型 主页 简体中文 English 简体中文
登录 BPG Management System F6Publishing-Submit a Manuscript F6Publishing-世界华人消化 …

Soins de support nutritionnels dans le parcours des patients atteints de cancers œsogastriques

A De Moura, A Turpin, C Neuzillet - Bulletin du Cancer, 2023 - Elsevier
Résumé Les soins de support occupent une place centrale dans la prise en charge des
patients atteints de cancers œsogastriques, à tous les stades de la maladie. La dénutrition a …